UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
{
"resourceType" : "AdministrableProductDefinition",
"id" : "VaxigripTetra-0.5ml-Suspension-SE-AJ-APD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: AdministrableProductDefinition VaxigripTetra-0.5ml-Suspension-SE-AJ-APD</b></p><a name=\"VaxigripTetra-0.5ml-Suspension-SE-AJ-APD\"> </a><a name=\"hcVaxigripTetra-0.5ml-Suspension-SE-AJ-APD\"> </a><a name=\"hcVaxigripTetra-0.5ml-Suspension-SE-AJ-APD-en-US\"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href=\"MedicinalProductDefinition-VaxigripTetra-0.5ml-Suspension-SE-AJ-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100005958-00053400,http://ema.europa.eu/fhir/eurdId#10298; domain = human use; status = Current; combinedPharmaceuticalDoseForm = Suspension for injection in pre-filled syringe; indication = VaxigripTetra är avsett för att förebygga influensa orsakad av de två subtyper av influensa A virus och två typer av influensa B virus som finns i vaccinet för: - aktiv immunisering av vuxna, inklusive gravida kvinnor, och barn från 6 månader och uppåt - passivt skydd av nyfödda och spädbarn under 6 månader efter vaccinering av gravida kvinnor (se avsnitt 4.4, 4.6 och 5.1) Användning av VaxigripTetra ska bedömas på basis av officiella rekommendationer.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = influenza, inactivated, split virus or surface antigen</a></p><p><b>administrableDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073864}\">Suspension for injection</span></p><p><b>producedFrom</b>: <a href=\"ManufacturedItemDefinition-VaxigripTetra-0.5ml-Suspension-SE-AJ-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = suspension for injection; unitOfPresentation = syringe</a></p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073600}\">Intramuscular use</span></p></blockquote><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073633}\">Subcutaneous use</span></p></blockquote></div>"
},
"status" : "active",
"formOf" : [
{
🔗 "reference" : "MedicinalProductDefinition/VaxigripTetra-0.5ml-Suspension-SE-AJ-MPD"
}
],
"administrableDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
"code" : "100000073864",
"display" : "Suspension for injection"
}
]
},
"producedFrom" : [
{
🔗 "reference" : "ManufacturedItemDefinition/VaxigripTetra-0.5ml-Suspension-SE-AJ-MID"
}
],
"routeOfAdministration" : [
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073345",
"code" : "100000073600",
"display" : "Intramuscular use"
}
]
}
},
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073345",
"code" : "100000073633",
"display" : "Subcutaneous use"
}
]
}
}
]
}